GET an adme quote
Assay Card
Investigating Tumour Cell Killing Through 2D and 3D Assays
Immune cells like T cells, NK cells, and macrophages have the potential to eliminate cancer cells, but their cytotoxic functions require adequate activation, which is often hindered by the tumour microenvironment. Novel cancer immunotherapies aim to understand the mechanisms leading to sub-optimal immune cell activation in cancer patients and develop strategies to overcome them.
Alternatively, search our entire resource library below
Show filters
Sort by
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Showing 0 items
No items found.
Poster
Priming of Spheroids with IFN-γ Increases Efficacy of T cell Mediated Killing with PD-1 Blockade
%20(2).jpg)
No items found.
Poster
Identifying Disease Relevant Macrophage Subtypes in vitro using RNA-Sequencing Transcriptome Profiling
No items found.
Poster
In vitro and Ex vivo models of OPC maturation and myelination for drug discovery
No items found.
Flyer
T Cell Activation Assays
In vivo/Ex vivo Toxicology
Poster
In Vitro method development for studying comparative induction of UGTs using primary rat and human hepatocytes
Immunology
Immuno-oncology
Cell Based Assays
Cell Lines
Flyer
T Cell Killing Assays: how to choose the right one
Neuroscience
Neurodegeneration
Brochure
Neuroinflammation Brochure
No results found.
There are no results with this criteria. Try changing your search.